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Abstract
Objective To determine whether a difference in systolic blood pressure
readings between arms can predict a reduced event free survival after
10 years.
Design Cohort study.
Setting Rural general practice in Devon, United Kingdom.
Participants 230 people receiving treatment for hypertension in primary
care.
Intervention Bilateral blood pressure measurements recorded at three
successive surgery attendances.
Main outcome measures Cardiovascular events and deaths from all
causes during a median follow-up of 9.8 years.
Results At recruitment 24% (55/230) of participants had a mean interarm
difference in systolic blood pressure of 10 mm Hg or more and 9%
(21/230) of 15 mm Hg or more; these differences were associated with
an increased risk of all cause mortality (adjusted hazard ratio 3.6, 95%
confidence interval 2.0 to 6.5 and 3.1, 1.6 to 6.0, respectively). The risk
of death was also increased in 183 participants without pre-existing
cardiovascular disease with an interarm difference in systolic blood
pressure of 10 mm Hg or more or 15 mm Hg or more (2.6, 1.4 to 4.8
and 2.7, 1.3 to 5.4). An interarm difference in diastolic blood pressure
of 10 mm Hg or more was weakly associated with an increased risk of
cardiovascular events or death.
Conclusions Differences in systolic blood pressure between arms can
predict an increased risk of cardiovascular events and all cause mortality
over 10 years in people with hypertension. This difference could be a
valuable indicator of increased cardiovascular risk. Bilateral blood
pressure measurements should become a routine part of cardiovascular
assessment in primary care.
Introduction
A difference in blood pressure readings between arms can be
observed in various general populations,
1 2 healthy women
duringtheantenatalperiod,
3 4andpopulationswithanincreased
riskofcardiovasculardisease,suchaspeoplewithhypertension,
5
diabetes,
6 7chronicrenaldisease,
8orperipheralvasculardisease.
9
The presence of a difference between arm measurements has
been implicated in a delayed diagnosis of hypertension
10 and is
associated with a higher prevalence of poor control in
hypertension,
9 as failure to standardise measurement to the arm
with the highest reading can mislead decisions about
management. Current guidelines recognise the need to check
blood pressure in both arms
11 12 but this practice has not been
followedbymanyclinicians,
13 14includinggeneralpractitioners
in the United Kingdom,
15 and continues to be undertaken
selectively in primary care settings.
16 This poor uptake may in
part result from a lack of clearly presented supporting evidence
for this intervention that is relevant to primary care
practitioners.
17
The new clinical guideline for hypertension from the National
InstituteforHealthandclinicalExcellenceconsidersaninterarm
difference of less than 10 mm Hg to be normal and attributes a
difference of more than 20 mm Hg to underlying vascular
disease.
18 An evidence review for interarm differences in blood
pressure was outside the remit of this update; however, it did
not consider the group with an interarm difference in systolic
bloodpressureof10-20mmHg,despiteourprevioussystematic
review suggesting that this group represents 15% of the
population with hypertension.
1
Our previous work has suggested that an interarm difference in
bloodpressureisanindependentpredictorofreducedeventfree
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Research
RESEARCHsurvival.
5 19 Others have also shown an association with
increasedmortalityinpeopleathigherriskofvasculardisease,
8 9
and the need for further studies carried out in primary care
settings has been highlighted.
9 We further analysed an
established primary care cohort to determine to what extent the
differenceinsurvivalobservedatfiveyearspersistsat10years.
5
Methods
The Mid Devon Medical Practice operates three separate
surgeries in a rural area. This study was carried out in the main
surgery (list size 1900). Eligible participants were those
registered with the author (CEC) and receiving treatment for
hypertension. Hypertension was defined by the then current
guidelines of the British Hypertension Society (≥160/100 mm
Hg or ≥140/90 mm Hg in the presence of target organ damage,
diabetes, or coronary heart disease risk score ≥15%).
20 We
excluded participants on the basis of anatomical criteria (loss,
previous injury, surgery above wrist level, or paralysis of one
arm) or for practical reasons—that is, the inability or
unwillingness to regularly attend the surgery for review.
Measurements
Atrecruitmentoneinvestigator(CEC)measuredbloodpressure
using a standard mercury sphygmomanometer (Accoson; AC
Cossor,Harlow,Essex),whichwascalibratedeverysixmonths.
Standard or large cuffs were used as appropriate. Pairs of blood
pressurereadingswerecollectedsequentiallyaftertheparticipant
hadbeenseatedforfiveminutes;measurementwastakeninthe
arm first presented without prompting, and the cuff was then
swapped to the other arm and another measurement taken. The
arm was supported during each measurement. We obtained
single pairs of measurements at the first and subsequent two
visits and recruitment ran from 9 November 1999 to 17 June
2002. Return visits were planned every six months if blood
pressure was controlled, or at shorter intervals if treatment for
high blood pressure was being adjusted. We averaged the three
pairs of readings to obtain a mean systolic and diastolic blood
pressure for each arm to derive the mean interarm difference.
Afterthefirstvisitwerecordedtheparticipant’smedicalhistory
and characteristics (age, sex, smoking status, body mass index,
glucose level, total cholesterol level, creatinine level,
pre-treatment blood pressure, years since diagnosis of
hypertension, evidence of left ventricular hypertrophy on
electrocardiogram, and Framingham risk score calculated from
pre-treatment values extracted from patient records). If such
data were missing we undertook the necessary investigations.
Drugs were adjusted to achieve optimal blood pressure control
according to guidelines, but we did not include use of drugs in
the dataset.
20 We prospectively collected data on events until
26 April 2011. Events were defined as death (cardiovascular or
all cause using death certification data augmented where
availablebypostmortemfindings)ornon-fatalcerebrovascular
events, and cardiovascular events (myocardial infarction or a
new diagnosis of angina), confirmed after referral to secondary
care.
Data analysis
We entered anonymised data on an Excel spreadsheet and used
SPSSPredictiveAnalyticsSoftwareStatisticsv18.0.0andStata
v11.1 for analysis. Left ventricular hypertrophy was diagnosed
byelectrocardiographyatrecruitmentusingthePerugiascoring
system,
21andwecalculatedscoresfortheriskofcoronaryheart
disease at 10 years from the Framingham equation.
22 We
comparedtheparticipant’scharacteristicsatentrytothecohorts
usingtorχ
2testsbetweengroupsaccordingtopredefinedcut-off
points of interarm differences that have been used in the
literature and in our previous report—namely, 10 mm Hg or
more and 15 mm Hg or more differences in systolic blood
pressure and 10 mm Hg or more differences in diastolic blood
pressure. At each of these cut-off points we used Kaplan-Meier
survival plots to compare the time to death (all cause and
cardiovascular), combined non-fatal cardiovascular and
cerebrovascular events, and death or non-fatal events. We used
a Cox’s proportional hazards regression model to calculate the
unadjusted hazard ratios for these outcomes, fitting interarm
difference as either a continuous variable or using the defined
cut-off points. A multivariable Cox regression model was used
toderiveadjustedhazardratios,whichincludedtheFramingham
risk score (model 1) and, in addition, included mean blood
pressure (systolic for analyses of systolic interarm difference,
and diastolic for analyses of diastolic interarm difference,
calculated as the mean of three pairs (n=6) of blood pressure
measurements at recruitment), presence of diabetes, and
pre-existing cardiovascular or peripheral vascular disease on
entry to the cohort (model 2). Regardless of their statistical
effect we included these variables in the model for their
relevanceonclinicalgrounds.Toassessthespecificcontribution
ofinterarmdifferencesinbloodpressure,weusedthelikelihood
ratio test to assess the reduction in goodness of fit arising as the
result of omitting the interarm difference term from each of the
adjusted models. A predefined secondary analysis was
undertaken in the subgroup of participants without previous
cardiovascular disease at entry to the cohort. We assessed
proportionality of hazards over time by plotting
−ln(−ln(survival))versusln(analysistime),andtestedthisusing
Schoenfeld residuals.
23 24 (Also see web extra on bmj.com.) We
found no major violations of the proportional hazards
assumption. The competing risk of death was accounted for by
censoringatthedateofdeath.Inmortalityoutcomemodels,we
considered any previous non-fatal events to be uninformative.
Results
Of 273 patients (14.3% of surgery list) eligible for inclusion,
247 (90%) were recruited by June 2002 and 230 (84%) with
complete data were analysed (fig 1⇓). No participants were lost
to follow-up. Participants not included in the analysis were
significantly older but did not differ in any other respect from
the cohort analysed (table 1⇓). The median time to collection
ofallthreesetsofreadingswasfourmonths(interquartilerange
2-12months).Atrecruitment,55(24%)participantshadamean
interarm difference in systolic blood pressure of 10 mm Hg or
more and 21 (9%) a difference of 15 mm Hg or more (fig 2⇓);
14 (6%) participants had an interarm difference in diastolic
blood pressure of 10 mm Hg or more. The mean difference in
systolicbloodpressurewas1.5mmHg(95%confidenceinterval
0.4to2.6)higherintherightarmandindiastolicbloodpressure
was 1.7 mm Hg (1.1 to 2.3) higher in the left arm.
The median time to final analysis or to a fatal event was 9.8
years (interquartile range 0.4-11.4 years). During the study
period, 52 cardiovascular and 27 cerebrovascular events
occurred in 76 participants. Fifty nine participants died and a
total of 100 (44%) participants had an event or died.
All case analysis
There were no differences in the baseline characteristics of
participants above and below an interarm difference in systolic
blood pressure of 10 mm Hg or more or 15 mm Hg or more or
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RESEARCHan interarm difference in diastolic blood pressure of 10 mm Hg
or more (table 2⇓).
Inbothunadjustedandadjustedanalysesaninterarmdifference
in systolic blood pressure of 10 mm Hg or more and 15 mm Hg
or more were both associated with increases in the hazard of
cardiovascular events, cardiovascular mortality, all cause
mortality,andcombinednon-fataleventsorallcausemortality.
Hazard ratios for all cause mortality after full adjustment were
3.6(95%confidenceinterval2.0to6.5)forinterarmdifferences
in systolic blood pressure of 10 mm Hg or more (fig 3⇓) and
3.1 (1.6 to 6.0) for differences of 15 mm Hg or more (table 3⇓).
Thiscorrespondedtoa5-6%increaseinthehazardofoutcomes
for each 1 mm Hg increment in interarm difference for systolic
blood pressure (table 4⇓). An interarm difference in diastolic
blood pressure of 10 mm Hg or more was associated, with less
precision, with increases in the hazard of cardiovascular events
and combined non-fatal events or all cause mortality in both
unadjusted and adjusted analyses: adjusted hazard ratios 3.8
(95% confidence interval 1.8 to 8.6) and 3.3 (1.6 to 6.8),
respectively. After adjustment this corresponded to a 9%
increase in hazard of any fatal or non-fatal event for each 1 mm
Hgincrementininterarmdifferencefordiastolicbloodpressure.
Across all models for systolic blood pressure the likelihood
ratio test showed a significant reduction in goodness of fit on
removal of interarm difference, with the exception of
cardiovascular mortality associated with a difference of 15 mm
Hg or more, indicating that inclusion of interarm differences in
systolicbloodpressureconsistentlyimprovedthepredictability
of models. This was also shown for an interarm difference in
diastolic blood pressure of 10 mm Hg or more with non fatal
events and combined events and deaths (tables 3 and 4).
Analyses without pre-existing cardiovascular
disease
At recruitment 183 participants had no pre-existing
cardiovascular disease; 28% (n=51) had an interarm difference
insystolicbloodpressureof10mmHgormoreand11%(n=20)
a difference of 15 mm Hg or more, and 6% (n=11) had an
interarm difference in diastolic blood pressure of 10 mm Hg or
more.Inthissubgroup,sensitivityanalysesofpredefinedlevels
of interarm differences in both systolic and diastolic blood
pressures were examined for differences in mortality and event
free survival. The findings of unadjusted and adjusted Cox
regression analyses were consistent with the full case analysis,
showing increases in the hazards of cardiovascular events,
cardiovascular mortality, all cause mortality, and combined
events or deaths in both unadjusted and adjusted analyses for
interarm differences in systolic blood pressure of 10 mm Hg or
moreor15mmHgormore;hazardratiosforallcausemortality
were 2.6 (95% confidence interval 1.4 to 4.8; fig 4⇓) and 2.7
(1.3 to 5.4). An interarm difference in diastolic blood pressure
of 10 mm Hg or more was associated with an increased hazard
of cardiovascular events, and combined non-fatal events or all
cause mortality after adjustment: hazard ratios 3.2 (1.3 to 8.1)
and 2.4 (1.0 to 5.9); table 5⇓. When interarm difference was
analysed as a continuous variable, the hazard of all outcomes
increased by a consistent 5% for each 1 mm Hg increment in
interarm difference in systolic blood pressure after adjustment.
In the continuous model the hazard ratios for an interarm
differenceindiastolicbloodpressurewerenolongersignificant
(table 4). Associated reductions in goodness of fit were seen on
removal of interarm differences in systolic blood pressure from
the models.
Stratified analysis
In primary prevention of cardiovascular disease a 10 year
cardiovascular risk score of more than 20% over 10 years
represents a threshold for intervention with statin therapy.
25
Participants without pre-existing cardiovascular disease were
therefore stratified by both their conventional risk score (above
or below the threshold of 20%) and their interarm difference in
systolic blood pressure (above or below 10 mm Hg). Analysis
showed that the presence of an interarm difference in systolic
blood pressure of 10 mm Hg or more without pre-existing
disease, but where the cardiovascular risk score was more than
20%, was associated with a significantly higher hazard of
combined fatal and non-fatal events compared with those with
an interarm difference in systolic blood pressure of less than 10
mm Hg but equivalent cardiovascular risk score (log rank
statistic25.9,P<0.001)andalsoahigherhazardwhencompared
with those with pre-existing disease (log rank statistic 4.5,
P<0.05; fig 5⇓).
Discussion
A difference in systolic blood pressure between arms of 10 mm
Hg or more or 15 mm Hg or more in people with hypertension
in primary care was associated with a reduction in event free
survival over 10 years. This association held for the study
population when participants with pre-existing cardiovascular
disease were included or excluded and, compared with our
earlieranalysisat4.7years’follow-up,thesurvivalcurveshave
continued to diverge. The presence of an interarm difference in
systolic blood pressure of 10 mm Hg or more in participants
not known to have cardiovascular disease at recruitment but
with a high cardiovascular risk score of more than 20% at
baseline, seems to confer a level of risk for events of similar
magnitude to that of participants with previously diagnosed
cardiovascular disease.
Strengths and limitations of the study
One investigator (CEC) gathered all the data. In designing this
study, a sequential method of measurement was chosen as a
pragmatic test within the consultation. A recent meta-analysis
has suggested that a simultaneous, automated repeated
measurement method with one or two machines should be the
ideal for epidemiological study,
26 and we also, subsequent to
establishingthisstudy,showedthatasimultaneousmeasurement
technique reduces bias.
1 Studies relevant to the general
population using such techniques
27-31 have reported lower
prevalences of an interarm difference in blood pressure than
those using sequential measurements.
2 19 29 32-38 However,
subsequent sampling of the study cohort presented here, using
a robust simultaneous measurement technique, showed similar
prevalence rates for interarm differences of 10 mm Hg or more
of 19% for systolic blood pressure and 7% for diastolic blood
pressure (compared with the 23% and 6% reported here).
39 One
study also reported a strong correlation of interarm differences
when comparing three simultaneous and three sequentially
gathered pairs of readings, and a correlation remained when
measurementswererepeatedatalaterdate.
40Wehavepresented
data suggesting that a single sequential pair of measurements
can reliably rule out an interarm difference in blood pressure
withhighnegativepredictivevalue,
41andournewmeta-analysis
has shown no difference in the strength of association between
peripheral vascular disease and systolic interarm differences in
bloodpressureaccordingtothemethodofmeasurement.
42Given
currentknowledge,ifdesigningthisstudynowwewouldadopt
an automated simultaneous measurement method, although we
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RESEARCHbelieve that our pragmatic approach remains relevant to “real
world” practice.
43
Thelackofstrictrandomisationoftheorderofarmmeasurement
could have introduced bias, as blood pressure measurements
will often decrease during repetition.
11 No strict first arm
preference was adopted, however, and the small absolute
difference in blood pressure in favour of right or left arms is in
keeping with previously reported large series and suggests that
nosystematicbiaswasintroduced.
19 27 32 44TheinvestigatorCEC
was not blinded to data collection, but because events were
recorded prospectively over 10 years, and our definitions of
non-fatal events required independent diagnosis in secondary
care, we do not believe that this lack of blinding could have
biased the survival outcomes reported. We did not collect data
on drug use at recruitment or changes in use during the study
period, so cannot comment on potential survival differences
due to drugs.
This is a small study from one rural general practice. The
reported prevalence of participants receiving treatment for
hypertension in this study was 14.3% of the list, comparable to
the 13.7% for women and 11.7% for men reported at the time
by the health survey for England.
45 Therefore we believe that
these findings can be generalised to other similar cohorts of
peoplewithhypertensionbeingtreatedinprimarycare,although
the lack of representation of ethnic minority groups in Devon
is a recognised limitation. Conversely, this rural practice has a
lowturnoverofpatients,facilitatinglongtermfollow-up,which
we see as a strength.
Based on the previous analysis of this cohort, giving a hazard
ratio of 2.5 for the composite outcome of mortality or event at
acut-offpointforinterarmdifferenceinsystolicbloodpressure
of 10 mm Hg, we estimated that we would have required a total
of 50 observed events to achieve 90% power and 62 to achieve
95%power.Inthisfollow-upweobserved108deathsorevents.
1
Highercut-offvalueswereinitiallyincludedintheanalysisplan
to permit comparison with other survival studies
8 9; however,
the diminishing numbers of participants with an interarm
difference in systolic blood pressure of more than 15 mm Hg
meantareducedprecisionoftheeventresultsforhigherinterarm
differences,theseanalysesarethereforenotincludedinthedata
presented.
Comparison with existing literature
Prevalence of an interarm difference in blood pressure varies
with the population studied and tends to be higher in the
presence of hypertension.
29 37 46 Whether this reflects a truly
higherprevalenceorismerelyafunctionofhigherachievement
ofanarbitrarycut-offpointwhereabsolutevaluesareincreased
isunclear,buttheprevalencevaluesreportedhereareconsistent
with our previous meta-analysis of similar cohorts measured
with robust techniques.
1
Some previous series have suggested a bias towards higher
readings from the right arm,
2 31 33 36-38 47 48 whereas others have
failed to show this
19 27 32 44 46 49; studies looking specifically at
left or right handedness have also failed to show an association
with the arm producing the higher reading.
29 31 This study has
not found a consistent bias to one side for interarm differences
in either systolic or diastolic blood pressures, and shows that
measurement using both arms at initial assessment is required
to avoid future underestimation of blood pressure owing to an
unrecognised difference between arms. In fact the direction of
mean differences in systolic and diastolic blood pressures was
opposite, in keeping with some other reported series, and we
suggest this may be related to differing pulse pressures along
the aorta.
31 50 Current guidance suggests that an interarm
differenceoflessthan10mmHgcanbeconsideredtobenormal
and that differences of 20/10 mm Hg or more warrant specialist
referral.
18 51 Previous studies have proposed a normal range for
differences in systolic or diastolic blood pressure of up to 10
mmHg
27andithasbeenarguedfromothercrosssectionalseries
thatthehighprevalenceofdifferencesabovethesecut-offpoints
implies that this is a physiological rather than a pathological
finding.
44 50 Our recent meta-analysis has, however, shown that
an interarm difference in systolic blood pressure of 10 mm Hg
or more or 15 mm Hg or more is associated with peripheral
vascular disease in cross sectional studies, with a pooled risk
ratio of 2.4 or 2.5, respectively.
42 Peripheral vascular disease is
recognised as a risk factor for future cardiovascular events and
mortality,
52 and we have previously proposed that an interarm
difference in blood pressure is due to peripheral vascular
disease.
53 An interarm difference in systolic blood pressure of
15 mm Hg or more is associated with angiographic evidence of
carotid or aortic artery disease,
54 and vascular disease of the
arms is associated with hypertension.
55 Thus evidence supports
theassociationofaninterarmdifferencewithexistingperipheral
vascular disease, and we propose that this accounts for the
survival differences seen.
Twootherprospectivestudieshavereportedincreasedmortality
withaninterarmdifferenceinsystolicbloodpressure;thelarger
studyreportedasignificantsurvivaldifferencewithadifference
of 15 mm Hg or more. Three cohorts were combined in that
paper and differences were not significant for the cohort
recruited from the community; only total deaths were
significantly higher in one of the two cohorts recruited from
vascular clinics.
9 The other study, of renal and general medical
out-patients,showedsignificantlyhigherratesofeventsordeath
for an interarm difference in systolic blood pressure of 10 mm
Hg or more.
8 Meta-analysis to combine data for an interarm
difference in systolic blood pressure of 15 mm Hg or more
presentedherewiththreeothercohorts
9waspossibleandshowed
pooled hazard ratios for all cause mortality of 1.6 (95%
confidence interval 1.1 to 2.3) and for cardiovascular related
mortalityof1.7(1.1to2.5).
42Thusthereissupportingevidence
from other studies that an interarm difference in blood pressure
is a predictor of cardiovascular events and death in populations
at high baseline cardiovascular risk.
Implications for clinical practice
Guidelinesadvocatethemeasurementofbloodpressureinboth
armsaspartoftheinitialassessmentofhypertension.
11 12Failure
to recognise a difference can lead to underestimation or
under-treatment of blood pressure, but this guidance is not
routinely followed in primary care
13-15 and the additional time
required to measure both arms has been cited as a practical
problem.
6 56 It is postulated that this poor uptake may be due in
parttoalackofevidencethoughttoberelevantbyprimarycare
practitioners,
17 and guidelines should make use of available
evidence rather than consensus views where evidence does
exist.
42 The finding here of an additional cardiovascular risk
associated with an interarm difference in a representative
primary care cohort with hypertension is therefore important.
In this study, regression modelling showed the interarm
difference to be an independent variable associated with
increased risk of events or death, and in stratified analysis its
presence conferred a risk equivalent to established
cardiovascular disease. This would suggest that those with an
interarm difference may justifiably require aggressive
management along secondary prevention guidelines, such as
the addition of statin therapy, and potentially by adding
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RESEARCHantiplatelet treatment to their care; a strategy that remains of
unclear benefit in primary cardiovascular prevention.
57 This
seemsalogicalandpathologicallyplausibleproposalsincesuch
treatment is effective in secondary prevention and therefore
ought to be effective in primary prevention for selected cases
at the highest vascular risk; however, further work is needed to
justify this approach. We have suggested that the interarm
difference is a manifestation of occult peripheral vascular
disease,
53 which is known to confer an increased risk of events
or death
58 59 and is therefore managed with aggressive lifestyle
anddrugstrategies.Non-invasivestudieshaverepeatedlyshown
anassociationofinterarmdifferencesinsystolicbloodpressure
of 10 mm Hg or more
5 6 39 49 60 and 15 mm Hg or more
5 6 39 49 54 61-63
with peripheral vascular disease, and we consider that
confirmationofaninterarmdifferencemayindicatethatfurther
assessmentforthepresenceofperipheralvasculardiseaseshould
be undertaken.
42 To date, however, there are no studies of
relevant interventions on which to base clinical
recommendations.
Implications for future research
This study adds important information to the evidence base
supporting the need to detect an interarm difference in blood
pressure, not only to improve measurement and management
of hypertension but to consider the vascular risk to the patient.
The interarm difference in blood pressure has the potential to
act as a simple non-invasive test, identifying those who could
benefit from more intensive assessment—for example, by
measurement of ankle-brachial pressure index. This
measurement is not routinely undertaken in the primary care
assessment of patients with hypertension and is not included in
theNHShealthcheckprogramme.
64Itrequirestime,experience,
and training,
65 whereas bilateral brachial blood pressure
measurements can be easily taken. Therefore, further studies of
the association of interarm differences in blood pressure with
other manifestations of peripheral and cardiovascular disease,
in cohorts representative of the primary care population, would
be valuable.
Conclusions
An interarm difference in systolic blood pressure of 10 mm Hg
or more or 15 mm Hg or more predicts reduced mortality and
event free survival over 10 years in people with hypertension
in primary care. This study supports the potential value of an
interarm difference as a simple clinical indicator of increased
cardiovascular risk. Assessment of blood pressure in both arms
is recommended by guidelines and should become a core
component of initial blood pressure measurement in primary
care. Detection of an interarm difference should prompt
consideration of further vascular assessment and aggressive
management of risk factors.
We thank the staff and patients of the Mid Devon Medical Practice for
their support and participation in this study.
Contributors: CEC conceived the study, collected the data, undertook
primary analyses, and drafted the manuscript. RST undertook and
supervised data analysis and contributed to the manuscript. ACS and
JLC advised on data analysis and presentation and contributed to the
manuscript. CEC wlll act as guarantor for this study.
Funding: This research was supported by the Scientific Foundation
Board of the Royal College of General Practitioners (grant No
SFB-2009-06), the South West GP Trust, and the National Institute for
Health Research (NIHR) Peninsula Collaboration for Leadership in
Applied Health Research and Care, a NIHR funded collaboration of the
Peninsula College of Medicine and Dentistry, University of Exeter,
University of Plymouth, and NHS South West. The project was also
supported by the NIHR Peninsula Clinical Research Facility. The views
and opinions expressed in this paper are those of the authors and not
necessarily those of the NHS, the NIHR, or the Department of Health.
Competing interests: All authors have completed the ICMJE uniform
disclosure form at www.icmje.org/coi_disclosure.pdf (available on
request from the corresponding author) and declare: no support from
any organisation for the submitted work; no financial relationships with
any organisations that might have an interest in the submitted work in
the previous three years; and no other relationships or activities that
could appear to have influenced the submitted work.
Ethical approval: This study was approved by the North and East Devon
Research Ethics Committee (No 2000/12/158).
Data sharing: No additional data available.
1 Clark CE, Campbell JL, Evans PH, Millward A. Prevalence and clinical implications of the
inter-arm blood pressure difference: a systematic review. J Hum Hypertens
2006;20:923-31.
2 Cassidy P, Jones K. A study of inter-arm blood pressure differences in primary care. J
Hum Hypertens 2001;15:519-22.
3 Ray WT. Assessment of blood pressure discrepancies in third-trimester hypertensive
gravidas. AANA J 2000;68:525-30.
4 Poon LCY, Kametas N, Strobl I, Pachoumi C, Nicolaides KH. Inter-arm blood pressure
differences in pregnant women. BJOG 2008;115:1122-30.
5 Clark CE, Powell RJ, Campbell JL. The interarm blood pressure difference as predictor
of cardiovascular events in patients with hypertension in primary care: cohort study. J
Hum Hypertens 2007;21:633-6.
6 Clark CE, Greaves C, Evans PH, Dickens A, Campbell JL. The interarm blood pressure
difference in type 2 diabetes: a barrier to effective management? Br J Gen Pract
2009;59:428-32.
7 Kleefstra N, Houweling ST, Meyboom D, Bilo HJG. Measuring the blood pressure in both
arms is of little use; longitudinal study into blood pressure differences between both arms
and its reproducibility in patients with diabetes mellitus type 2. Nederlands tijdschrift voor
geneeskunde 2007;151:1509-14.
8 Agarwal R, Bunaye Z, Bekele DM. Prognostic significance of between-arm blood pressure
differences. Hypertension 2008;51:657-62.
9 Aboyans V, Criqui MH, McDermott MM, Allison MA, Denenberg JO, Shadman R, et al.
The vital prognosis of subclavian stenosis. J Am Coll Cardiol 2007;49:1540-5.
10 Banks MJ, Erb N, George P, Pace A, Kitas GD. Hypertension is not a disease of the left
arm: a difficult diagnosis of hypertension in Takayasu’s arteritis. J Hum Hypertens
2001;15:573-5.
11 Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. Guidelines for
management of hypertension: report of the fourth working party of the British Hypertension
Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
12 Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007
guidelines for the management of arterial hypertension: the Task Force for the Management
of Arterial Hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
13 Gosse P. Blood pressure should be measured in both arms on the first consultation
[comment]. J Hypertens 2002;20:1045-6.
14 Materson B. Inter-arm blood pressure differences. J Hypertens 2004;22:2267-8.
15 Heneghan C, Perera R, Mant D, Glasziou P. Hypertension guideline recommendations
in general practice: awareness, agreement, adoption, and adherence. Br J Gen Pract
2007;57:948-52.
16 Clark CE, Smith LFP, Harding G, Taylor RS, Campbell JL. Nurse led hypertension clinics:
evolving ahead of the evidence? J Hum Hypertens 2011;25:S6.
17 Parker E, Glasziou P. Use of evidence in hypertension guidelines: should we measure
in both arms? Br J Gen Pract 2009;59:e87-92.
18 National Institute for Health and Clinical Excellence. Hypertension: the clinical management
of primary hypertension in adults, CG127. NICE, 2011.
19 Clark CE, Powell RJ. The differential blood pressure sign in general practice: prevalence
and prognostic value. Fam Pract 2002;19:439-41.
20 Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, et al. Guidelines
for management of hypertension: report of the third working party of the British
Hypertension Society. J Hum Hypertens 1999;13:569-92.
21 Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, et al. Improved
electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994;74:714-9.
22 Hingorani AD, Vallance P. A simple computer program for guiding management of
cardiovascular risk factors and prescribing. BMJ 1999;318:101-5.
23 Collett D. Modelling survival data in medical research. 2nd ed. Chapman & Hall/CRC,
2003.
24 Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika
1982;69:239-41.
25 JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical
practice. Heart 2005;91(suppl 5):v1-52.
26 Verberk WJ, Kessels AGH, Thien T. Blood pressure measurement method and inter-arm
differences, a meta-analysis. Am J Hypertens 2011: published online 21 July.
27 Orme S, Ralph SG, Birchall A, Lawson-Matthew P, McLean K, Channer KS. The normal
range for inter-arm differences in blood pressure. Age Ageing 1999;28:537-42.
28 Gould BA, Hornung RS, Kieso HA, Altman DG, Raftery EB. Is the blood pressure the
same in both arms? Clin Cardiol 1985;8:423-6.
29 Harrison EG, Roth GM, Hines EA. Bilateral indirect and direct arterial pressures. Circulation
1960;22:419-36.
30 Fotherby MD, Panayiotou B, Potter JF. Age-related differences in simultaneous interarm
blood pressure measurements. Postgrad Med J 1993;69:194-6.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e1327 doi: 10.1136/bmj.e1327 (Published 20 March 2012) Page 5 of 13
RESEARCHWhat is already known on this topic
A difference in blood pressure readings between arms is frequently observed in various general populations
An interarm difference in systolic blood pressure has been associated with increased mortality in selected secondary care populations
at high vascular risk
What this study adds
In a primary care cohort with hypertension, an interarm difference in systolic blood pressure of 10 mm Hg or more or 15 mm Hg or more
was associated with an increased risk of cardiovascular and all cause mortality over 10 years
For people with hypertension but no pre-existing cardiovascular disease, an interarm difference in systolic blood pressure seems to
confer a level of risk equivalent to that of people with hypertension and pre-existing cardiovascular disease
Blood pressure measurement in both arms should become a routine part of cardiovascular assessment in primary care
31 Lane D, Beevers M, Barnes N, Bourne J, John A, Malins S, et al. Inter-arm differences
in blood pressure: when are they clinically significant? J Hypertens 2002;20:1089-95.
32 Singer AJ, Hollander JE. Blood pressure. Assessment of interarm differences. Arch Intern
Med 1996;156:2005-8.
33 Kay WE, Gardner KD. Comparative blood pressures in the two arms. Cal West Med
1930;33:578-9.
34 Israel E. Differences in blood pressure in both arms. Acta Med Orientalia 1944;3:86-9.
35 Hashimoto F, Hunt WC, Hardy L. Differences between right and left arm blood pressures
in the elderly. West J Med 1984;141:189-92.
36 Rueger MJ. Blood pressure variations in the two arms. Ann Intern Med 1951;35:1023.
37 Amsterdam B, Amsterdam AL. Disparity in blood pressures in both arms in normals and
hypertensives and its clinical significance. NY State J Med 1943;43:2294-300.
38 Korns KM, Guinand PH. Inequality of blood pressure in the brachial arteries, with especial
reference to disease of the arch of the aorta. J Clin Invest 1933;12:143.
39 Clark CE, Campbell JL, Powell RJ, Thompson JF. The inter-arm blood pressure difference
and peripheral vascular disease: cross sectional study. Fam Pract 2007;24:420-6.
40 Eguchi K, Yacoub M, Jhalani J, Gerin W, Schwartz JE, Pickering TG. Consistency of
blood pressure differences between the left and right arms. Arch Intern Med
2007;167:388-93.
41 Clark CE, Campbell JL, Evans PH, Shore A, Taylor R. Detection of an interarm blood
pressure difference in primary care diabetes care. Diabet Med 2009;26:128.
42 Clark CE, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL. The association of an
inter-arm difference in systolic blood pressure with vascular disease and mortality: a
systematic review and meta-analysis. Lancet : published online ahead of print 30 Jan
2012. www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961710-8/
abstract.
43 Clark CE. Inter-arm blood pressure measurement needs to be practical and accurate.
Am J Hypertens 2011;24:1189-90.
44 Pesola GR, Pesola HR, Lin M, Nelson MJ, Westfal RE. The normal difference in bilateral
indirect blood pressure recordings in hypertensive individuals. Acad Emerg Med
2002;9:342-5.
45 National Centre for Social Research. Health survey for England 2003. NatCen, 2003.
46 Kristensen BO, Kornerup HJ. Which arm to measure the blood pressure? Acta Med Scand
1982;670:69-73.
47 O’Shea JC, Murphy MB. Ambulatory blood pressure monitoring: which arm? J Hum
Hypertens 2000;14:227-30.
48 Southby R. Some clinical observations on blood pressure and their practical application,
with special reference to variation of blood pressure readings in the two arms. Med J Aust
1935;2:580.
49 Frank SM, Norris EJ, Christopherson R, Beattie C. Right and left arm blood pressure
discrepancies in vascular surgery patients. Anesthesiology 1991;75:457-63.
50 Pesola GR, Pesola HR, Nelson MJ, Westfal RE. The normal difference in bilateral indirect
blood pressure recordings in normotensive individuals. Am J Emerg Med 2001;19:43-5.
51 Beevers G, Lip GYH, O’Brien E. ABC of hypertension: blood pressure measurement.
BMJ 2001;322:981-5.
52 Ankle Brachial Index Collaboraton. Ankle brachial index combined with Framingham risk
score to predict cardiovascular events and mortality: a meta-analysis. JAMA
2008;300:197-208.
53 Clark CE. Difference in blood pressure between arms might reflect peripheral vascular
disease. BMJ 2001;323:399-400.
54 Baribeau Y, Westbrook B, Charlesworth D, Hearne M, Bradley W, Maloney C. Brachial
gradient in cardiac surgical patients. Circulation 2002;106(suppl 1):I11-3.
55 Sin Lau Y, Yeung J, Krishna Lingam M. Vascular disease of the upper limb. Modern
Hypertension Management 2005;5:9-12.
56 Anekwe L. Interarm BP disparity increases heart risk. Pulse 2007;10:17.
57 Fowkes FG, Price JF, Stewart MCW, Butcher I, Leng GC, Pell ACH, et al. Aspirin for
prevention of cardiovascular events in a general population screened for a low ankle
brachial index: a randomized controlled trial. JAMA 2010;303:841-8.
58 Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality
over a period of 10 years in patients with peripheral arterial disease. N Engl J Med
1992;326:381-6.
59 Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial
disease: importance of identifying the population at risk. Vasc Med 1997;2:221-6.
60 Kawamura T. Assessing ankle-brachial index (ABI) by using automated oscillometric
devices. Arq Bras Cardiol 2008;90:294-8.
61 Aboyans V, Kamineni A, Allison MA, McDermott MM, Crouse JR, Ni H, et al. The
epidemiology of subclavian stenosis and its association with markers of subclinical
atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis
2010;211:266-70.
62 Igarashi Y, Chikamori T, Tomiyama H, Usui Y, Hida S, Tanaka H, et al. Clinical significance
of inter-arm pressure difference and ankle-brachial pressure index in patients with
suspected coronary artery disease. J Cardiol 2007;50:281-9.
63 Shadman R, Criqui MH, Bundens WP, Fronek A, Denenberg JO, Gamst AC, et al.
Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular
diseases. J Am Coll Cardiol 2004;44:618-23.
64 Department of Health. Putting prevention first. Vascular checks: risk assessment and
management. DoH, 2008.
65 Ray SA, Srodon PD, Taylor RS, Dormandy JA. Reliability of ankle:brachial pressure index
measurement by junior doctors. Br J Surg 1994;81:188-90.
Accepted: 13 January 2012
Cite this as: BMJ 2012;344:e1327
This is an open-access article distributed under the terms of the Creative Commons
Attribution Non-commercial License, which permits use, distribution, and reproduction in
any medium, provided the original work is properly cited, the use is non commercial and
is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-
nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e1327 doi: 10.1136/bmj.e1327 (Published 20 March 2012) Page 6 of 13
RESEARCHTables
Table 1| Characteristics of people included and excluded from analyses. Values are numbers (percentages) unless stated otherwise
P value
Framingham score
Characteristics Incomplete data (n=17) Full data (n=230)
Continuous variables
<0.001* 79.2 (9.8) 68.1 (9.6) Mean (SD) age (years)
0.26* 26.9 (3.0) 27.9 (4.4) Mean (SD) body mass index
Mean baseline blood pressure (mm Hg):
0.37* 165.8 (23.4) 160.5 (17.0) Mean (SD) systolic
0.13* 89.5 (8.6) 86.1 (8.6) Mean (SD) diastolic
Dichotomous variables
0.17† 5 (29) 107 (47) Men
0.62‡ 0 (0) 18 (8) Diabetes
0.76‡ 4 (24) 47 (20) Pre-existing ischaemic heart disease or peripheral vascular disease
0.72‡ 4 (18) 32 (14) Smoker
0.40‡ 6 (35) 59 (26) Deaths (all causes)
1.00† 7 (41) 100 (44) Events or deaths
*t test.
†χ
2 test.
‡Fisher’s exact test.
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RESEARCHTable 2| Comparison of baseline variables and outcome measures for interarm differences in systolic blood pressure and in diastolic blood
pressure. Values are numbers (percentages) unless stated otherwise
Interarm difference in diastolic blood pressure (mm
Hg) Interarm difference in systolic blood pressure (mm Hg)
Variables P value ≥10 (n=14) <10 (n=216) P value ≥15 (n=21) <15 (n=209) P value ≥10 (n=55) <10 (n=175)
Continuous variables
0.49* 66.8 (7.2) 68.2 (9.7) 0.28* 70.7 (11.5) 67.9 (9.4) 0.16* 69.7 (10.1) 67.6 (9.4) Mean (SD) age (years)
0.23* 26.9 (2.7) 27.9 (4.5) 0.60* 27.4 (4.2) 27.9 (4.4) 0.23* 27.3 (3.6) 28.0 (4.6) Mean (SD) body mass
index
Mean baseline blood
pressure (mm Hg):
0.28* 167.1 (23.1) 160.1 (16.5) 0.44* 163.3 (19.2) 160.2 (16.8) 0.51* 161.8 (16.3) 160.1 (17.2) Systolic blood pressure
0.17* 90.6 (12.0) 85.8 (8.3) 0.98* 86.1 (6.0) 86.1 (8.8) 0.99* 86.1 (8.2) 86.1 (8.7) Diastolic blood pressure
0.75* 24.7 (11.9) 25.8 (12.1) 0.31* 28.4 (12.1) 25.5 (12.1) 0.058* 28.4 (11.7) 24.9 (12.1) Framingham 10 year risk
score (%)
Dichotomous variables
0.79† 7 (50) 100 (46) 0.72† 9 (43) 98 (47) 0.90† 26 (47) 81 (46) Male
0.61‡ 0 (0) 18 (8) 1.00‡ 1 (5) 17 (8) 0.39‡ 6 (11) 12 (7) Diabetes
1.00‡ 1 (3) 28 (13) 0.49‡ 1 (5) 28 (13) 0.17† 4 (7) 25 (14) Angina
0.33‡ 2 (14) 17 (8) 0.23‡ 0 (0) 19 (9) 0.26‡ 2 (4) 17 (10) Myocardial infarction
0.53† 0 (0) 17 (8) 0.43† 3 (14) 14 (7) 0.73† 5 (9) 12 (7) Cerebrovascular disease
0.27‡ 1 (7) 4 (2) 1.00‡ 0 (0) 5 (2) 0.34‡ 0 (0) 5 (3) Peripheral vascular
disease
1.00‡ 2 (14) 30 (14) 0.51‡ 4 (19) 28 (13) 0.55† 9 (16) 23 (13) Smoker
*t test.
†χ
2 test.
‡Fisher’s exact test.
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RESEARCHTable 3| Unadjusted and adjusted hazard ratios at predefined cut-off levels of interarm differences in blood pressure (n=230)
P value§ Adjusted hazard ratio model 2‡ P value†
Adjusted hazard ratio
model 1* Unadjusted hazard ratio Interarm differences
Combined cardiovascular and cerebrovascular events
Systolic blood pressure cut-off:
<0.001 2.8 (1.7 to 4.6) 0.001 2.2 (1.4 to 3.6) 2.5 (1.6 to 4.0) 10 mm Hg
0.005 2.8 (1.5 to 5.4) 0.024 2.2 (1.2 to 4.2) 2.5 (1.3 to 4.6) 15 mm Hg
Diastolic blood pressure cut-off:
0.004 3.8 (1.7 to 8.4) 0.046 2.3 (1.1 to 4.8) 2.3 (1.1 to 4.7) 10 mm Hg
Cardiovascular deaths
Systolic blood pressure cut-off:
0.002 4.2 (1.7 to 10.3) 0.007 2.9 (1.4 to 6.0) 3.4 (1.7 to 7.2) 10 mm Hg
0.085 2.7 (1.0 to 7.7) 0.251 1.8 (0.7 to 4.9) 2.4 (0.91 to 6.3) 15 mm Hg
Diastolic blood pressure cut-off:
0.194 2.5 (0.7 to 9.2) 0.312 2.0 (0.6 to 6.5) 1.7 (0.5 to 5.5) 10 mm Hg
All deaths
Systolic blood pressure cut-off:
<0.001 3.6 (2.0 to 6.5) <0.001 3.0 (1.8 to 5.0) 3.4 (2.0 to 5.7) 10 mm Hg
0.003 3.1 (1.6 to 6.0) 0.011 2.5 (1.3 to 4.7) 3.0 (1.6 to 5.6) 15 mm Hg
Diastolic blood pressure cut-off:
0.840 1.1 (0.3 to 3.7) 0.820 0.9 (0.3 to 2.8) 0.8 (0.2 to 2.5) 10 mm Hg
Non-fatal events or deaths
Systolic blood pressure cut-off:
<0.001 2.8 (1.8 to 4.3) <0.001 2.4 (1.6 to 3.6) 2.7 (1.8 to 4.0) 10 mm Hg
0.001 2.8 (1.6 to 4.9) 0.006 2.3 (1.3 to 4.0) 2.6 (1.5 to 4.4) 15 mm Hg
Diastolic blood pressure cut-off:
0.005 3.3 (1.6 to 6.8) 0.081 1.9 (1.0 to 3.9) 1.9 (1.0 to 3.9) 10 mm Hg
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio test from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure, presence of diabetes, and pre-existing vascular disease.
§P value for likelihood ratio test from omission of interarm differences from multivariable model 2.
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RESEARCHTable 4| Unadjusted and adjusted hazard ratios for absolute interarm differences in systolic and diastolic blood pressure (risk per mm Hg
difference)
P value§
Adjusted hazard ratio
model 2‡ P value†
Adjusted hazard ratio
model 1* Unadjustedhazardratio Interarm differences
All cases
Systolic blood pressure:
<0.001 1.05 (1.03 to 1.08) 0.002 1.04 (1.02 to 1.07) 1.06 (1.03 to 1.08) All events and deaths
0.001 1.06 (1.03 to 1.09) 0.003 1.04 (1.02 to 1.07) 1.06 (1.03 to 1.08) All deaths
0.050 1.05 (1.01 to 1.10) 0.145 1.03 (0.99 to 1.07) 1.05 (1.01 to 1.09) Cardiovascular deaths
Diastolic blood pressure:
0.024 1.09 (1.01 to 1.16) 0.192 1.05 (0.98 to 1.12) 1.05 (0.98 to 1.12) All events and deaths
0.460 1.04 (0.95 to 1.13) 0.910 1.01 (0.92 to 1.10) 1.00 (0.92 to 1.09) All deaths
0.600 1.04 (0.91 to 1.18) 0.934 1.00 (0.88 to 1.13) 1.00 (0.88 to 1.12) Cardiovascular deaths
No pre-existing cardiovascular disease
Systolic blood pressure:
0.001 1.05 (1.02 to 1.08) 0.001 1.05 (1.02 to 1.08) 1.06 (1.04 to 1.09) All events and deaths
0.008 1.05 (1.02 to 1.08) 0.020 1.04 (1.01 to 1.06) 1.06 (1.03 to 1.08) All deaths
0.115 1.05 (1.00 to 1.10) 0.179 1.03 (0.99 to 1.07) 1.06 (1.02 to 1.10) Cardiovascular deaths
Diastolic blood pressure:
0.143 1.06 (0.98 to 1.15) 0.503 1.03 (0.95 to 1.11) 1.03 (0.95 to 1.10) All events and deaths
0.770 1.02 (0.91 to 1.14) 0.680 0.98 (0.88 to 1.09) 0.97 (0.88 to 1.07) All deaths
0.997 1.00 (0.85 to 1.18) 0.812 0.98 (0.84 to 1.15) 0.97 (0.84 to 1.13) Cardiovascular deaths
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio test from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure, presence of diabetes, and pre-existing vascular disease (for all cases analyses).
§P value for likelihood ratio test from omission of interarm differences from multivariable model 2.
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RESEARCHTable 5| Unadjusted and adjusted hazard ratios at predefined levels of interarm differences in blood pressure in participants without
pre-existing vascular disease (n=183)
P value§ Adjusted hazard ratio model 2‡ P value† Adjusted hazard ratio model 1* Unadjusted hazard ratio Interarm difference
Combined cardiovascular and cerebrovascular events
Systolic blood pressure cut-off:
<0.001 3.0 (1.7 to 5.3) <0.001 3.1 (1.8 to 5.5) 3.5 (2.1 to 6.1) 10 mm Hg
0.002 3.2 (1.6 to 6.4) 0.005 2.9 (1.5 to 5.5) 3.3 (1.7 to 6.3) 15 mm Hg
Diastolic blood pressure cut-off:
0.032 3.2 (1.2 to 7.9) 0.129 2.1 (0.9 to 4.8) 2.1 (0.9 to 4.9) 10 mm Hg
Cardiovascular deaths
Systolic blood pressure cut-off:
0.007 3.7 (1.4 to 9.9) 0.002 4.2 (1.7 to 10.8) 5.5 (2.2 to 13.8) 10 mm Hg
0.079 2.8 (1.0 to 8.3) 0.170 2.2 (0.8 to 6.0) 3.1 (1.1 to 8.5) 15 mm Hg
Diastolic blood pressure cut-off:
0.418 2.1 (0.4 to 11.0) 0.452 1.8 (0.4 to 8.0) 1.6 (0.4 to 6.8) 10 mm Hg
All deaths
Systolic blood pressure cut-off:
0.002 2.6 (1.4 to 4.8) 0.001 2.8 (1.5 to 5.0) 3.4 (1.9 to 6.1) 10 mm Hg
0.012 2.7 (1.3 to 5.4) 0.026 2.3 (1.2 to 4.6) 3.0 (1.5 to 6.0) 15 mm Hg
Diastolic blood pressure cut-off:
0.891 1.1 (0.3 to 4.8) 0.679 0.8 (0.2 to 3.1) 0.7 (0.2 to 2.7) 10 mm Hg
Events or deaths
Systolic blood pressure cut-off:
<0.001 2.7 (1.7 to 4.4) <0.001 2.8 (1.8 to 4.5) 3.2 (2.0 to 5.0) 10 mm Hg
0.002 2.8 (1.6 to 5.1) 0.003 2.6 (1.5 to 4.6) 2.8 (1.7 to 5.3) 15 mm Hg
Diastolic blood pressure cut-off:
0.080 2.4 (1.0 to 5.9) 0.401 1.5 (0.6 to 3.4) 1.5 (0.6 to 3.4) 10 mm Hg
*Adjusted for Framingham 10 year cardiovascular risk score.
†P value for likelihood ratio testing from omission of interarm differences from multivariable model 1.
‡Adjusted as for model 1 plus mean blood pressure and presence of diabetes.
§P value for likelihood ratio testing from omission of interarm differences from multivariable model 2.
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RESEARCHFigures
Fig 1 Flow of participants through study
Fig 2 Distribution of interarm difference (mean of right arm minus mean of left arm) in systolic blood pressure (SBP) in
study sample of 230 people with hypertension
Fig 3 Kaplan-Meier plot for all cause mortality in 230 people with hypertension with or without an interarm difference in
systolic blood pressure (SBP) of ≥10 mm Hg
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RESEARCHFig 4 Kaplan-Meier plot for all cause mortality in 183 people with hypertension without cardiovascular disease at recruitment,
with or without an interarm difference in systolic blood pressure (SBP) of ≥10 mm Hg
Fig 5 Kaplan-Meier survival curve for fatal and non-fatal events stratified by pre-existing cardiovascular disease (CVD) at
recruitment, cardiovascular risk score, and interarm difference in systolic blood pressure (SBP) ≥10 mm Hg (n=230)
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